← Back

Alfresa Holdings Corporation

Alfresa Holdings Corporation, through its subsidiaries, manufactures, wholesales, markets, and imports/exports pharmaceuticals, diagnostic reagents, and medical devices and equipment in Japan and internationally. It also operates dispensing pharmacies and related businesses, including ethical pharmaceuticals wholesaling, self-medication products wholesaling, and other medical-related operations. In addition, the company manufactures and markets active pharmaceutical ingredients, provides contract distribution services in hospitals, and handles information system operation, maintenance, and development, along with the supply of cell raw materials and the manufacturing of specific processed cells and regenerative medicine products. Incorporated in 2003, the company is based in Tokyo, Japan.

Country

Japan

Sector

Health Care Distributors

Also in

Diagnostics & Precision Testing

Price · split & dividend adjusted

News & notes moving 2784.JP

2784.JP▼

Alfresa Holdings first-quarter consolidated net profit falls 50.5% to 2.476 billion yen

Alfresa Holdings reported consolidated results for the April-to-June quarter, with net profit falling 50.5% year on year to 2.476 billion yen. Details on revenue and other profit items were not disclosed, but the company saw a sharp decline in profit. Alfresa Holdings is a holding company centered on pharmaceutical wholesale.

2784.JP ▼

時事通信·45dRead more →